We suppose that EPHA3 targets through the PI3K-Akt signaling pathway to wake up the antigen recognition of the immune-infiltrating cells (such as CD8+ cells) to achieve the purpose of killing the BLCA cells in vivo. Here, EPHA3 is linked to bladder transitional cell carcinoma.